| Market Cap | ₹5,334Cr |
| ROE | 6.35% |
| P/E Ratio(TTM) | 38.85 |
| EPS(TTM) | 7.02 |
| P/B Ratio | 2.19 |
| Dividend Yield | 0.18% |
| Industry P/E | 31.80 |
| Book Value | 124.61 |
| Debt to Equity | 0.24 |
| Face Value | 1 |
| Managing Director | Mr. Vishnukant Chaturbhuj Bhutada |
| Founded | 1987 |
| NSE Symbol | SHILPAMED |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Torrent Pharmaceuticals | NA (0.00%) | 62.99 | ||
| Ajanta Pharma | NA (0.00%) | 34.83 | ||
| Gland Pharma | NA (0.00%) | 35.33 | ||
| Eris Lifesciences | NA (0.00%) | 42.70 |